Blood amyloid and tau biomarkers as predictors of cerebrospinal fluid profiles

to related objects

Location
Deutsche Nationalbibliothek Frankfurt am Main
ISSN
1435-1463
Extent
Online-Ressource
Language
Englisch
Notes
online resource.

Bibliographic citation
Blood amyloid and tau biomarkers as predictors of cerebrospinal fluid profiles ; volume:129 ; number:2 ; day:15 ; month:2 ; year:2022 ; pages:231-237 ; date:2.2022
Journal of neural transmission ; 129, Heft 2 (15.2.2022), 231-237, 2.2022

Creator
Delaby, Constance
Alcolea, Daniel
Hirtz, Christophe
Vialaret, Jérôme
Kindermans, Jana
Morichon, Lisa
Fortea, Juan
Belbin, Olivia
Gabelle, Audrey
Blennow, Kaj
Zetterberg, Henrik
Lleó, Alberto
Lehmann, Sylvain
Contributor
SpringerLink (Online service)

DOI
10.1007/s00702-022-02474-9
URN
urn:nbn:de:101:1-2022052521295663904399
Rights
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
Last update
15.08.2025, 7:26 AM CEST

Data provider

This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Show original at data provider

Associated

  • Delaby, Constance
  • Alcolea, Daniel
  • Hirtz, Christophe
  • Vialaret, Jérôme
  • Kindermans, Jana
  • Morichon, Lisa
  • Fortea, Juan
  • Belbin, Olivia
  • Gabelle, Audrey
  • Blennow, Kaj
  • Zetterberg, Henrik
  • Lleó, Alberto
  • Lehmann, Sylvain
  • SpringerLink (Online service)

Other Objects (12)

Moving fluid biomarkers for Alzheimer’s disease from research tools to routine clinical diagnostics

Moving fluid biomarkers for Alzheimer’s disease from research tools to routine clinical diagnostics

Amyloid and tau cerebrospinal fluid biomarkers in HIV infection

Amyloid and tau cerebrospinal fluid biomarkers in HIV infection

Cerebrospinal fluid tau, neurogranin, and neurofilament light in Alzheimer's disease

Cerebrospinal fluid tau, neurogranin, and neurofilament light in Alzheimer's disease

Serum and cerebrospinal fluid neurofilament light chain in patients with central nervous system infections caused by varicella-zoster virus

Serum and cerebrospinal fluid neurofilament light chain in patients with central nervous system infections caused by varicella-zoster virus

Cognitive impairment without altered levels of cerebrospinal fluid biomarkers in patients with encephalitis caused by varicella-zoster virus: a pilot study

Cognitive impairment without altered levels of cerebrospinal fluid biomarkers in patients with encephalitis caused by varicella-zoster virus: a pilot study

Cerebrospinal fluid N-224 tau helps discriminate Alzheimer’s disease from subjective cognitive decline and other dementias

Cerebrospinal fluid N-224 tau helps discriminate Alzheimer’s disease from subjective cognitive decline and other dementias

Salivary Biomarkers for Alzheimer’s Disease and Related Disorders

Salivary Biomarkers for Alzheimer’s Disease and Related Disorders

Fluid biomarkers in Alzheimer’s disease – current concepts

Fluid biomarkers in Alzheimer’s disease – current concepts

Mass Spectrometric Analysis of Cerebrospinal Fluid Ubiquitin in Alzheimer's Disease and Parkinsonian Disorders

Mass Spectrometric Analysis of Cerebrospinal Fluid Ubiquitin in Alzheimer's Disease and Parkinsonian Disorders

Plasma concentrations of glial fibrillary acidic protein, neurofilament light, and tau in Alexander disease

Plasma concentrations of glial fibrillary acidic protein, neurofilament light, and tau in Alexander disease

Plasma phospho-tau in Alzheimer’s disease: towards diagnostic and therapeutic trial applications

Plasma phospho-tau in Alzheimer’s disease: towards diagnostic and therapeutic trial applications

Targeting LAMP2 in human cerebrospinal fluid with a combination of immunopurification and high resolution parallel reaction monitoring mass spectrometry

Targeting LAMP2 in human cerebrospinal fluid with a combination of immunopurification and high resolution parallel reaction monitoring mass spectrometry

Related objects